Bioeffect Introduces 3xGF Line for Post-Procedure Skin Care

Bioeffect, an Icelandic skincare brand established 15 years ago, is introducing its new 3xGF range to the U.S. via Dermstore, select medical offices, and medi spas. The new line, including a serum and an eye serum priced between $149 and $329, leverages three growth factors: epidermal growth factor, keratinocyte growth factor, and interleukin-1 alpha, aimed at enhancing post-procedural recovery.

This launch aligns with the growing trend of integrating skincare into professional and post-procedural contexts, a market worth $8.4 billion globally, with the U.S. as a significant player. Industry forecasts anticipate $3.5 million in sales during the first year, although this estimate is unconfirmed by the company. Bioeffect plans to expand the range and emphasizes the importance of data-backed efficacy, with ongoing clinical tests and collaborations with dermatologists like Dr. Anetta Reszko, Dr. Ava Shamban, and Dr. Jessica Weiser.